I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

Supervisor - Production

Full-TimeUpdated on 10/15/2026
No salary listed
Mid, Senior
Bachelor's, Associate's
Santo Domingo, Dominican Republic
In Person
Manufacturing & Production Operations

About the job

Requirements
  • A bachelor's degree in Engineering or a Business-related discipline, or a high school diploma or associate's degree combined with five years of experience leading people and teams.
  • Three to five years of experience in a manufacturing environment.
  • Proven experience with Lean Manufacturing concepts.
  • Ability to lead, take leadership actions, create and share a coordinated vision, and align the organization on what needs to be done.
  • Ability to execute plans by prioritizing daily activities and focusing on the critical few.
  • Strong communication, interpersonal, decision-making, and problem-solving skills; bias for action.
  • Ability to work in a team environment and establish an expectation that the team comes before self.
Responsibilities
  • Adhere to Integer's values and all safety, environmental, security, quality, regulatory, policy, and operating-procedure requirements, including Quality Management Systems, Safety, Environmental and Security Management Systems, and U.S. Food and Drug Administration regulations.
  • Provide direct supervision to manufacturing associates in one or more value streams or departments to achieve safety, quality, cost, delivery, and people performance goals.
  • Coordinate resources and equipment efficiently to achieve production goals.
  • Execute operating plans and regularly update Value Stream maps.
  • Lead sustained change by ensuring production monitoring and improvement activities and execution of Leader Standard Work.
  • Standardize workplace organization and visual controls (5S), Manufacturing Standard Work, and training and certification programs.
  • Promote associate engagement through standardized problem-solving methodologies, behavior-based safety programs, and improvement idea suggestion systems.
  • Optimize systems and processes through built-in quality, optimized scheduling and material system designs, work cell design, and total productive maintenance.
  • Set daily, weekly, and monthly objectives and communicate them to associates.
  • Promote an environment of diversity, open communication, and trust.
  • Mentor associates and lead the development of their skills to meet future needs.
  • Promote a culture of quality across the team, assure adherence to the Quality Management System, facilitate corrective and preventive actions, contribute to quality KPI attainment, and support the journey to 5 Sigma.
  • Manage through Gemba walks, observations, and questions; engage with team members throughout the site and across functions to identify process-improvement opportunities.
  • Execute production plans with planning, customer service, and other teams to meet customer requirements using lean manufacturing principles, variation reduction, and waste elimination.
  • Audit processes and products, including 5S, safety, quality, and production, to ensure associates follow company policies and procedures.
  • Communicate between shifts and departments to implement best practices, resolve problems, and sustain performance objectives.
  • Support environmental, health, safety, and security as the top priority to keep associates safe and engaged.
  • Ensure products meet quality and integrity standards through adherence to the Quality Management System and quality metric KPIs.
  • Improve utilization and efficiency of resources and equipment by identifying lean and continuous-improvement opportunities and delivering results.
  • Coordinate the production area to achieve schedules and deliver products on time.
  • Promote engagement and ensure associate relations issues are handled in a timely manner.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

-1%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.